Stay updated on Dupilumab in Chinese Adults with Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Chinese Adults with Atopic Dermatitis Clinical Trial page.

Latest updates to the Dupilumab in Chinese Adults with Atopic Dermatitis Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2. Removed the previous government funding/operating status notices (Revision: v3.4.1) from the page.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a government funding lapse notice and NIH Clinical Center status update. Updated the site to Revision v3.4.1, replacing v3.4.0.SummaryDifference0.3%

- Check28 days agoChange DetectedNon-content updates include adding a Show glossary option, updating QC-related text from 'Last Update Submitted that met QC Criteria' to 'Last Update Submitted that Met QC Criteria', adjusting capitalization for 'No FEAR Act Data', and updating the site revision label to 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check64 days agoChange DetectedFooter now shows Revision: v3.3.3; HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2; no substantive study content changes are indicated. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Dupilumab in Chinese Adults with Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Chinese Adults with Atopic Dermatitis Clinical Trial page.